Viral Immunotherapy Reduces Recurrences in Early Prostate Cancer

By News Health
2 months Ago

(MedPage Today) — CHICAGO — An investigational viral immunotherapy (CAN-2409; aglatimagene besadenovec) combined with a prodrug improved disease-free survival (DFS) when added to standard curative-intent radiotherapy for newly diagnosed localized…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115909

Author :

Publish date : 2025-06-04 19:50:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Preterm Birth Predicts Adult Health Problems

Refine Your Application as Residency Deadline Approaches

How Safe Is Robotic Surgery?

JAK Inhibitors Raise Venous Thromboembolism Risk in AD

Here's Who Made This Year's List of Top Hospitals

At Least 60% of Liver Cancers Tied to Preventable Risk Factors